TAAR1 and Sepsis: Our findings suggest that Tα1, VitC, and Tα1 + VitC treatment in the early proinflammatory phase of sepsis may improve immune function in rats with sepsis, attenuating the overly dysregulated inflammatory response, reducing inflammatory damage, and protecting organ function.